FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316928263> ?p ?o ?g. }

• W4316928263 endingPage "235" @default.
• W4316928263 startingPage "235" @default.
• W4316928263 abstract "Importance An increased risk of venous thromboembolism (VTE) has been reported in men with an additional sex chromosome. The association between other sex chromosome aneuploidies and VTE is not well characterized. Objective To determine if sex chromosome aneuploidy is associated with VTE. Design, Setting, and Participants Retrospective cohort study of sex chromosome aneuploidy and VTE, performed by analyzing X- and Y-chromosome dosage and VTE incidence in 642 544 individuals from 2 population-scale biobanks: the US Geisinger MyCode Community Health Initiative (N = 154 519) and the UK Biobank (N = 488 025); analysis was limited to participants self-identified as White because of inadequate sample sizes for other race and ethnicity groups. A total of 108 461 unrelated MyCode participants with electronic health record follow-up ranging from September 1996 to December 2020 and 418 725 unrelated British and Irish UK Biobank participants who attended the baseline assessment between March 2006 and October 2010, with follow-up extending to November 2020, were included in analyses of VTE. Exposures Sex chromosome aneuploidies. Main Outcomes and Measures Individuals with 1 primary inpatient VTE diagnosis, 2 primary outpatient VTE diagnoses, or a self-reported VTE diagnosis were defined as VTE cases. P values were adjusted for multiple comparisons. Results Identification of sex chromosome aneuploidy was undertaken among 642 544 individuals aged 18 to 90 years. Identification of a diagnosis of VTE was undertaken among 108 461 unrelated MyCode participants (65 565 [60.5%] female; mean age at last visit, 58.0 [SD, 17.6] years; median follow-up, 15.3 [IQR, 9.7] years) and among 418 725 unrelated UK Biobank participants (224 695 [53.7%] female; mean age at baseline interview, 56.9 [SD, 8.0] years; median follow-up, 12.0 [IQR, 1.6] years). Among MyCode participants, during 10 years of follow-up, 17 incident VTE events per 1353 person-years were detected among those with supernumerary sex chromosome aneuploidy (1.3% per person-year) compared with 2060 per 816 682 person-years among those with 46,XX or 46,XY (0.25% per person-year) (hazard ratio, 5.4 [95% CI, 3.4-8.7]; 10-year risk difference, 8.8% [95% CI, 4.2%-14.0%]; P &amp;lt; .001). Among UK Biobank participants, during 10 years of follow-up, 16 incident VTE events per 3803 person-years were detected among those with supernumerary sex chromosome aneuploidy (0.42% per person-year) compared with 4491 per 3 970 467 person-years among those with 46,XX or 46,XY (0.11% per person-year) (hazard ratio, 4.1 [95% CI, 2.5-6.7]; 10-year risk difference, 3.7% [95% CI, 1.4%-5.9%]; P &amp;lt; .001). Conclusions and Relevance Adults with supernumerary sex chromosome aneuploidies compared with 2 sex chromosomes had a small but statistically significant increased risk of VTE. Further research is needed to understand the clinical implications of this association." @default.
• W4316928263 created "2023-01-18" @default.
• W4316928263 creator A5020019979 @default.
• W4316928263 creator A5041794949 @default.
• W4316928263 creator A5042557122 @default.
• W4316928263 creator A5042626961 @default.
• W4316928263 creator A5056063509 @default.
• W4316928263 creator A5057324254 @default.
• W4316928263 creator A5074636830 @default.
• W4316928263 creator A5088638156 @default.
• W4316928263 date "2023-01-17" @default.
• W4316928263 modified "2023-10-03" @default.
• W4316928263 title "Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism" @default.
• W4316928263 cites W1913957972 @default.
• W4316928263 cites W1960171603 @default.
• W4316928263 cites W1964393492 @default.
• W4316928263 cites W1984300721 @default.
• W4316928263 cites W2022932023 @default.
• W4316928263 cites W2035955026 @default.
• W4316928263 cites W2044201733 @default.
• W4316928263 cites W2092322472 @default.
• W4316928263 cites W2099085143 @default.
• W4316928263 cites W2399758458 @default.
• W4316928263 cites W2406652206 @default.
• W4316928263 cites W2443172870 @default.
• W4316928263 cites W2723723801 @default.
• W4316928263 cites W2790546909 @default.
• W4316928263 cites W2806538597 @default.
• W4316928263 cites W2890773078 @default.
• W4316928263 cites W2894676574 @default.
• W4316928263 cites W2909325382 @default.
• W4316928263 cites W2913705661 @default.
• W4316928263 cites W2951438521 @default.
• W4316928263 cites W2981730965 @default.
• W4316928263 cites W3005860721 @default.
• W4316928263 cites W3016595631 @default.
• W4316928263 cites W3021845969 @default.
• W4316928263 cites W3041803284 @default.
• W4316928263 cites W3214936554 @default.
• W4316928263 cites W4249214711 @default.
• W4316928263 cites W4281669505 @default.
• W4316928263 doi "https://doi.org/10.1001/jama.2022.23897" @default.
• W4316928263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36648468" @default.
• W4316928263 hasPublicationYear "2023" @default.
• W4316928263 type Work @default.
• W4316928263 citedByCount "1" @default.
• W4316928263 crossrefType "journal-article" @default.
• W4316928263 hasAuthorship W4316928263A5020019979 @default.
• W4316928263 hasAuthorship W4316928263A5041794949 @default.
• W4316928263 hasAuthorship W4316928263A5042557122 @default.
• W4316928263 hasAuthorship W4316928263A5042626961 @default.
• W4316928263 hasAuthorship W4316928263A5056063509 @default.
• W4316928263 hasAuthorship W4316928263A5057324254 @default.
• W4316928263 hasAuthorship W4316928263A5074636830 @default.
• W4316928263 hasAuthorship W4316928263A5088638156 @default.
• W4316928263 hasBestOaLocation W43169282632 @default.
• W4316928263 hasConcept C104317684 @default.
• W4316928263 hasConcept C126322002 @default.
• W4316928263 hasConcept C187212893 @default.
• W4316928263 hasConcept C2779672484 @default.
• W4316928263 hasConcept C2908647359 @default.
• W4316928263 hasConcept C29456083 @default.
• W4316928263 hasConcept C30481170 @default.
• W4316928263 hasConcept C54355233 @default.
• W4316928263 hasConcept C71924100 @default.
• W4316928263 hasConcept C72563966 @default.
• W4316928263 hasConcept C86803240 @default.
• W4316928263 hasConcept C99454951 @default.
• W4316928263 hasConceptScore W4316928263C104317684 @default.
• W4316928263 hasConceptScore W4316928263C126322002 @default.
• W4316928263 hasConceptScore W4316928263C187212893 @default.
• W4316928263 hasConceptScore W4316928263C2779672484 @default.
• W4316928263 hasConceptScore W4316928263C2908647359 @default.
• W4316928263 hasConceptScore W4316928263C29456083 @default.
• W4316928263 hasConceptScore W4316928263C30481170 @default.
• W4316928263 hasConceptScore W4316928263C54355233 @default.
• W4316928263 hasConceptScore W4316928263C71924100 @default.
• W4316928263 hasConceptScore W4316928263C72563966 @default.
• W4316928263 hasConceptScore W4316928263C86803240 @default.
• W4316928263 hasConceptScore W4316928263C99454951 @default.
• W4316928263 hasIssue "3" @default.
• W4316928263 hasLocation W43169282631 @default.
• W4316928263 hasLocation W43169282632 @default.
• W4316928263 hasLocation W43169282633 @default.
• W4316928263 hasOpenAccess W4316928263 @default.
• W4316928263 hasPrimaryLocation W43169282631 @default.
• W4316928263 hasRelatedWork W1521584897 @default.
• W4316928263 hasRelatedWork W2035277224 @default.
• W4316928263 hasRelatedWork W2315085516 @default.
• W4316928263 hasRelatedWork W2316407790 @default.
• W4316928263 hasRelatedWork W2603773853 @default.
• W4316928263 hasRelatedWork W2618612696 @default.
• W4316928263 hasRelatedWork W2763828104 @default.
• W4316928263 hasRelatedWork W2782729394 @default.
• W4316928263 hasRelatedWork W2964295425 @default.
• W4316928263 hasRelatedWork W3037790712 @default.
• W4316928263 hasVolume "329" @default.
• W4316928263 isParatext "false" @default.

• next